Results 91 to 100 of about 12,800 (198)

EFFECTIVENESS OF DESMOPRESSIN AND OXYBUTYNIN HCL IN THE TREATMENT OF NOCTURNAL ENURESIS

open access: yesThe Iraqi Journal of Medical Sciences, 2004
Background: Nocturnal enuresis is an innocent but distressing disorder occurring in many children which may lead to poor self-esteem.   Objectives: To evaluate the response of a group of children with nocturnal enuresis to intranasal Desmopressin ...
doaj   +1 more source

Selection of AVP-Shortage Patients as Candidates for Low-Dose Oral Desmopressin Administration

open access: yesResearch and Reports in Urology, 2021
Takumi Takeuchi,1 Kazuki Maki,1 Yumiko Okuno,1 Mami Hattori-Kato,2 Koji Mikami1 1Department of Urology, Japan Organization of Occupational Health and Safety, Kanto Rosai Hospital, Nakahara-ku, Kawasaki, Japan; 2Department of Urology, Tokyo Teishin ...
Takeuchi T   +4 more
doaj  

MOESM1 of Serum sodium and intracranial pressure changes after desmopressin therapy in severe traumatic brain injury patients: a multi-centre cohort study

open access: yes, 2019
Additional file 1. Evolution of daily urine output in patients who received desmopressin and those who did not (A). Evolution of serum sodium (B) and intracranial pressure (C) from 24 h prior to the first desmopressin administration until 72 h after ...
G. Citerio (7350875)   +18 more
core   +1 more source

Desmopressin AND FESS

open access: yes, 2022
This study aimed to evaluate the effect of local nasal desmopressin premedication on blood loss and the quality of surgical field in FESS.THIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF FILES AND ACCESS THE FILES IN THIS
Jalali, M (via Mendeley Data)   +1 more
core   +1 more source

LITHIUM-INDUCED NEPHROGENIC DIABETES INSIPIDUS RESPONSIVE TO DESMOPRESSIN

open access: yes, 2019
WOS: 000485206400020PubMed: 31508188Nephrogenic diabetes insipidus (NDI) is the most common renal side effect seen with lithium therapy. Persisting cases after the cessation of the therapy may be seen when lithium therapy is continued for too long ...
Kayataş, K.   +2 more
core   +1 more source

Desmopressin (DDAVP): indications and practicalities

open access: yesSwiss Medical Weekly
BACKGROUND: Desmopressin (1-deamino-8-D-arginine vasopressin, or DDAVP) is available in Switzerland for the treatment of non-severe haemophilia A and von Willebrand disease.
Eugenia Biguzzi   +9 more
doaj   +1 more source

Effects of Tirzepatide Therapy on Arginine Vasopressin Deficiency: A Case with Reduced Desmopressin Requirement

open access: yesEndocrinology Research and Practice
Arginine vasopressin deficiency (AVP-D) is a rare endocrine disorder that causes polyuria and polydipsia. The case of a 45-year-old woman with AVP-D who showed a marked reduction in urine output and desmopressin requirement after starting tirzepatide ...
Elif Yivli, Ömercan Topaloğlu
doaj   +3 more sources

Nocturnal Enuresis In Children

open access: yesJournal of Bahria University Medical and Dental College, 2019
Nocturnal enuresis is one of the commonest developmental problem specially in our country. It can cause emotional family stress and social isolation of child.
Asiya Kazi   +3 more
doaj   +1 more source

Desmopressin Acetate in Intracranial Haemorrhage

open access: yes, 2020
Introduction. The secondary increase in the size of intracranial haematomas as a result of spontaneous haemorrhage or trauma is of particular relevance in the event of prior intake of platelet aggregation inhibitors.
Sabine Struve   +6 more
core  

Desmopressin-assoziierte symptomatische Wasserintoxikation mit Hyponatriämie und konsekutivem Krampfanfall

open access: yes, 2008
ZusammenfassungIn unsere Klinik erfolgte die Aufnahme eines bislang normal entwickelten 4 -jährigen Jungen mit einem tonisch- klonischen afebrilen Krampfanfall.
Manuela Schulz   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy